NS5A Inhibitor (GlaxoSmithKline)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNS5A Inhibitor (GlaxoSmithKline)
Drug Alias NameHCV non structural protein (Genelabs)NS5A Inhibitor (Genelabs)naphthalene derivatives (GlaxoSmithKline)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 5A inhibitors
TargetsNonstructural protein 5A
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenelabs Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcGenelabs Technologies Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A